The association between LMNA mutation, lipodystrophy, and cardiac involvement (heart conduction disorders, valvulopathies, and/or cardiomyopathies) has been amply reported, usually manifesting clinically after the third decade, with very high penetrance by the age of 70 years [26]. This evidence concerns the gene LMNA and cardiac conduction defect.